DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 1,036 filers reported holding DANAHER CORPORATION in Q4 2015. The put-call ratio across all filers is 0.70 and the average weighting 0.6%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2017 | $9,000 | 0.0% | 110 | 0.0% | 0.00% | 0.0% |
| Q1 2017 | $9,000 | -96.3% | 110 | -96.4% | 0.00% | -96.6% |
| Q4 2016 | $241,000 | +11.1% | 3,091 | +11.9% | 0.06% | +9.3% |
| Q3 2016 | $217,000 | -16.2% | 2,763 | +7.8% | 0.05% | -21.7% |
| Q2 2016 | $259,000 | +27.0% | 2,562 | +19.4% | 0.07% | +16.9% |
| Q1 2016 | $204,000 | +7.9% | 2,146 | +5.6% | 0.06% | +3.5% |
| Q4 2015 | $189,000 | +9.2% | 2,032 | 0.0% | 0.06% | +5.6% |
| Q3 2015 | $173,000 | -27.6% | 2,032 | -27.1% | 0.05% | -18.2% |
| Q2 2015 | $239,000 | +31.3% | 2,789 | +30.4% | 0.07% | +29.4% |
| Q1 2015 | $182,000 | -13.3% | 2,139 | -12.8% | 0.05% | +21.4% |
| Q4 2014 | $210,000 | +41.9% | 2,452 | +26.1% | 0.04% | +50.0% |
| Q3 2014 | $148,000 | -3.3% | 1,944 | 0.0% | 0.03% | -3.4% |
| Q2 2014 | $153,000 | +2.0% | 1,944 | -2.9% | 0.03% | -3.3% |
| Q1 2014 | $150,000 | -0.7% | 2,002 | +2.1% | 0.03% | +42.9% |
| Q4 2013 | $151,000 | +12.7% | 1,961 | +1.8% | 0.02% | 0.0% |
| Q3 2013 | $134,000 | +35.4% | 1,927 | +23.7% | 0.02% | +31.2% |
| Q2 2013 | $99,000 | – | 1,558 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Defender Capital, LLC. | 345,428 | $39,965,000 | 17.38% |
| ARTHUR M. COHEN & ASSOCIATES, LLC | 276,826 | $36,547,000 | 13.04% |
| Eos Focused Equity Management, L.P. | 58,266 | $7,692,000 | 9.98% |
| Bodenholm Capital AB | 204,595 | $27,011,000 | 9.90% |
| CORTLAND ASSOCIATES INC/MO | 446,012 | $58,883,000 | 9.52% |
| MIROVA | 128,368 | $16,947,000 | 9.18% |
| Flossbach von Storch AG Zurich | 50,275 | $6,637,000 | 8.09% |
| Ostrum Asset Management U.S., LLC | 211,464 | $27,917,000 | 7.77% |
| Circle Road Advisors LP | 45,446 | $6,000,000 | 6.49% |
| Eversept Partners, LP | 158,764 | $20,985,459 | 6.12% |